During the upcoming term 2014-2016, I will focus with the support of the Board on the following objectives:
Interventional cardiovascular medicine is one the most vibrant and innovative disciplines within cardiology and has contributed immensely to improve patient outcome. The Association will build on previous efforts to further excel scientific knowledge and standards in several ways
The advent of transcatheter valve interventions is one of the most important recent advances in our field and cardiology as a whole. The Association will continue to advance this subspecialty in numerous ways
The prolific development in several domains including coronary interventions, transcatheter heart valve interventions, structural heart disease interventions, neurohumoral denervation and interventional pharmacology pose an increasing responsibility to provide a common ground of knowledge and expertise. The Association will further raise educational standards by
Inequalities in access to care particularly among female patients with acute coronary syndromes have been recognised. Moreover, minimal invasive treatments such as transcatheter heart valve interventions are particularly beneficial among female elderly patients. The Association will help to address these and other issues via the dedicated EAPCI Women Committee.
Investment in the upcoming and future interventional cardiovascular community will be a top priority to attract the most talented individuals into our subspecialty. The Association has implemented the Young Committee which will continue to develop specific initiatives such as CathGO adapted to the needs of young interventional cardiologists in training.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved